Alcon Dividends
| Dividend/share amount | Ex-dividend Date | Payment Date | Dividend Yield | |
|---|---|---|---|---|
| Next Dividend | N/A | N/A | N/A | N/A |
| Last Dividend | CHF0.28 | 5/5/26 | 5/7/26 | 0.48% |
| Next Dividend | Calculator |
|---|---|
| Dividend/share amount | N/A |
| Ex-dividend Date | N/A |
| Payment Date | N/A |
| Dividend Yield | N/A |
| Last Dividend | |
|---|---|
| Dividend/share amount | CHF0.28 |
| Ex-dividend Date | 5/5/26 |
| Payment Date | 5/7/26 |
| Dividend Yield | 0.48% |
The next Alcon dividend is expected soon, leave us your email to let you know.
Alcon Dividend Calendar
| Event | Day |
|---|---|
| Last trading date | May 4, 2026 |
| Ex-date | May 5, 2026 |
| Record date | May 6, 2026 |
| Payable date | May 7, 2026 |
Alcon dividend history
| Ex-Date | Amount | Variation | Div. Yield |
|---|---|---|---|
| 2026 | CHF0.28 | 0.00% | 0.48% |
| 5/5/26 | CHF0.28 | 0.48% | |
| 2025 | CHF0.28 | 16.67% | 0.35% |
| 5/13/25 | CHF0.28 | 0.35% | |
| 2024 | CHF0.24 | 14.29% | 0.30% |
| 5/14/24 | CHF0.24 | 0.30% | |
| 2023 | CHF0.21 | 5.00% | 0.30% |
| 5/10/23 | CHF0.21 | 0.30% | |
| 2022 | CHF0.2 | 100.00% | 0.29% |
| 5/3/22 | CHF0.2 | 0.29% | |
| 2021 | CHF0.1 | 0.15% | |
| 5/4/21 | CHF0.1 | 0.15% |
Alcon Dividend Analysis
Alcon FAQ
Alcon has not announced its next dividend yet. Its most recent dividend was CHF0.28 per share.
Alcon has not announced its next payment date yet. Its most recent dividend was paid on May 7, 2026 to shareholders who held the shares before May 5, 2026.
The most recent dividend from Alcon was CHF0.28 per share, paid on May 7, 2026.
Alcon follows an annual dividend payment schedule, making the payment in May.
Last year, Alcon reported a dividend yield of 0.30%.
During the last fiscal year, Alcon recorded a payout ratio of 11.67%, indicating that profits are sufficient to cover dividends.
In the last 3 years, Alcon has increased its dividends for 2 consecutive years. The dividend growth was 5.00% last year.
Richemont
SMI
Roche GS
SMI
Zurich Insurance
SMI
Lonza
SMI
Swiss Re
SMI
Novartis
SMI